Results of Tc99m-Maraciclatide Scintigraphy in Subjects With Diabetes Mellitus and Heart Failure With Preserved Left Ventricular Ejection Fraction
Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis
The Role of the Novel 99mTc-NC100692 Tracer in Patients at High Risk or Known Breast Cancer
Detection of Aggressive Breast Tumors Using Tc-99m-NC100692
† Study has passed its completion date and status has not been verified in more than two years.